CTRI/2021/09/036579
Not yet recruiting
未知
Clinical and immunological responses to COVID-19 vaccination in Rheumatoid arthritis patients on treatment with DMARDsâ?? A Prospective Cohort Study
AIIMS Bibnagar0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified
- Sponsor
- AIIMS Bibnagar
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age \>18 years
- •Willing to participate in the study
- •Diagnosed case of rheumatoid arthritis (clinically, radiologically, laboratically)
- •Both seropositive and seronegative RA
- •On treatment with DMARDS (single or combination)
- •Intend to receive vaccine against COVID\-19
- •Post COVID\-19 (3month after recovery)
Exclusion Criteria
- •Cancer and other autoimmune/ Immune suppressants disorders
- •Patients on immunosuppressive therapy other than DMARDs
- •Allergy and Contraindication to vaccination
- •Patients with active SARS CoV\-2 infection
- •Patients on alternative systems of medicine for RA
- •Patients with known interstitial lung disease
- •Pregnant or breastfeeding woman
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Immune response and therapy assessment to COVID-19 Vaccinations in people with Diabetes Mellitus – an observational pilot studyE10E11Type 1 diabetes mellitusType 2 diabetes mellitusDRKS00024879Division Exercise Physiology and Metabolism60
Active, not recruiting
Phase 1
Humoral (antibodies) and cellular (white blood cells) immune response to COVID-19 vaccines in immunocompromised (people with impaired immune system) and healthy individuals – The CoVVac studyActive immunisation to prevent COVID-19 in immunocompromised individuals.MedDRA version: 23.1Level: PTClassification code 10084457Term: COVID-19 immunisationSystem Organ Class: 10042613 - Surgical and medical proceduresTherapeutic area: Health Care [N] - Population Characteristics [N01]EUCTR2021-001040-10-ATMedical University of Graz390
Completed
Not Applicable
Serological response to COVID-19 and association with MR containing vaccineCTRI/2021/01/030363niversity College of Medical Sciences90
Recruiting
Not Applicable
Study of immunologic response after COVID-19 vaccination in kidney transplant recipientsImmune response after COVID-19 vaccination in immunosuppressed patientsCovid-19vaccinekidney transplantimmunosuppressionTCTR20210611006Ratchadapiseksompotch Fund60
Completed
Not Applicable
Investigating the immune response to COVID-19 vaccination in lung transplantation patients (COVALENT study)NL-OMON22289niversity Medical Center Groningen (UMCG)180